IL111673A - 5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them - Google Patents

5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them

Info

Publication number
IL111673A
IL111673A IL11167394A IL11167394A IL111673A IL 111673 A IL111673 A IL 111673A IL 11167394 A IL11167394 A IL 11167394A IL 11167394 A IL11167394 A IL 11167394A IL 111673 A IL111673 A IL 111673A
Authority
IL
Israel
Prior art keywords
dihydropyrone derivatives
pharmaceutical compositions
compositions containing
dihydropyrone
derivatives
Prior art date
Application number
IL11167394A
Other languages
English (en)
Other versions
IL111673A0 (en
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/319,821 external-priority patent/US5789440A/en
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of IL111673A0 publication Critical patent/IL111673A0/xx
Publication of IL111673A publication Critical patent/IL111673A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/26—Thiols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
IL11167394A 1993-11-19 1994-11-17 5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them IL111673A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15544393A 1993-11-19 1993-11-19
US08/319,821 US5789440A (en) 1993-11-19 1994-10-12 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents

Publications (2)

Publication Number Publication Date
IL111673A0 IL111673A0 (en) 1995-01-24
IL111673A true IL111673A (en) 1999-04-11

Family

ID=26852339

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11167394A IL111673A (en) 1993-11-19 1994-11-17 5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (1) US5936128A (ro)
EP (1) EP0729463B1 (ro)
JP (1) JP3698435B2 (ro)
AT (1) ATE217871T1 (ro)
AU (1) AU680064B2 (ro)
BG (1) BG63012B1 (ro)
CA (1) CA2176041A1 (ro)
CZ (1) CZ291856B6 (ro)
DE (1) DE69430671T2 (ro)
DK (1) DK0729463T3 (ro)
EE (1) EE9600045A (ro)
ES (1) ES2176263T3 (ro)
FI (1) FI962021A (ro)
HR (1) HRP940936B1 (ro)
HU (1) HUT75225A (ro)
IL (1) IL111673A (ro)
MD (2) MD1560G2 (ro)
NO (1) NO315117B1 (ro)
NZ (1) NZ275318A (ro)
PL (1) PL180634B1 (ro)
PT (1) PT729463E (ro)
RO (1) RO117850B1 (ro)
RU (1) RU2160733C2 (ro)
SI (1) SI0729463T1 (ro)
SK (1) SK283240B6 (ro)
TJ (1) TJ320B (ro)
WO (1) WO1995014011A2 (ro)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515730A (ja) * 1995-10-16 2002-05-28 カイロン コーポレイション 遺伝子発現を変調する因子のスクリーニング方法
WO1997017981A1 (en) 1995-11-13 1997-05-22 Gerard Voerman Anti-viral isolates obtainable from leeches
US5834506A (en) * 1996-11-01 1998-11-10 Warner-Lambert Company Dihydropyrones with improved antiviral activity
US6087455A (en) * 1997-12-19 2000-07-11 Shell Oil Company Process for hydrogenation of macromolecular organic substrates
US6528510B1 (en) * 1998-09-11 2003-03-04 Warner-Lambert Company HIV protease inhibitors
DE10030094A1 (de) 2000-06-19 2001-12-20 Bayer Ag Phenylsubstituierte 5,6-Dihydro-pyron-Derivate
DE10100175A1 (de) * 2001-01-04 2002-07-11 Bayer Ag Hetarylsubstituierte Homotetram-und Homotetronsäuren
DOP2003000641A (es) 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
SI1781662T1 (sl) 2004-08-18 2011-07-29 Pfizer Zaviralci RNA-odvisne RNA-polimeraze hepatitisa C in sestavki in zdravljenja, v katerih se uporabljajo
US9012471B2 (en) * 2008-04-11 2015-04-21 The Trustees Of Columbia University In The City Of New York Glucose metabolism modulating compounds
WO2015070226A1 (en) 2013-11-11 2015-05-14 Kuality Herbceutics Llc Kava derived therapeutic compounds and methods of use thereof
CN108026084A (zh) * 2015-05-07 2018-05-11 夸利蒂赫布丘蒂克斯公司 治疗化合物及其使用方法
EP3468952B1 (en) * 2016-06-14 2020-11-25 Bristol-Myers Squibb Company 4-hydroxy-3-sulfonylpyridin-2(1h)-ones as apj receptor agonists
MA46546A (fr) 2016-10-17 2021-05-05 Genentech Inc Composés thérapeutiques et leurs procédés d'utilisation
GB201707856D0 (en) 2017-05-16 2017-06-28 Arctic Pharma As Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3206276A (en) * 1961-09-28 1965-09-14 Minerals Engineering Company Process for recovery of pure v2o5 from vanadium bearing materials
US3206476A (en) * 1962-06-04 1965-09-14 Sterling Drug Inc 3-substituted-4-hydroxy-6-aryl-2-pyrones and preparation
US3818046A (en) * 1972-12-18 1974-06-18 Dow Chemical Co Sulfur-containing hydroxy pyrones and alkali metal salts thereof
US3931235A (en) * 1972-12-18 1976-01-06 The Dow Chemical Company Process for preparing sulfur-containing hydroxy pyrones
IL85347A0 (en) * 1987-02-11 1988-07-31 May & Baker Ltd Cyclic diones
JPH03503635A (ja) * 1988-03-01 1991-08-15 ジ・アップジョン・カンパニー ヒトにおいて逆転写酵素を抑制するクマリン類
JPH03227923A (ja) * 1990-01-30 1991-10-08 Sawai Seiyaku Kk ひと免疫不全ウイルス疾患処置剤
EP0614599A4 (en) * 1991-11-18 1995-01-04 Motorola Inc User selectable noise reduction for a portable microphone.
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses

Also Published As

Publication number Publication date
DK0729463T3 (da) 2002-09-09
WO1995014011A3 (en) 1995-06-29
HRP940936A2 (en) 1997-08-31
JP3698435B2 (ja) 2005-09-21
ATE217871T1 (de) 2002-06-15
PL180634B1 (pl) 2001-03-30
DE69430671D1 (de) 2002-06-27
HRP940936B1 (en) 2003-12-31
BG63012B1 (bg) 2001-01-31
MD960172A (ro) 1999-01-31
IL111673A0 (en) 1995-01-24
EE9600045A (et) 1996-10-15
HUT75225A (en) 1997-04-28
DE69430671T2 (de) 2002-11-21
MD1560G2 (ro) 2001-07-31
CA2176041A1 (en) 1995-05-26
AU680064B2 (en) 1997-07-17
CZ291856B6 (cs) 2003-06-18
PT729463E (pt) 2002-10-31
PL314483A1 (en) 1996-09-16
RO117850B1 (ro) 2002-08-30
JPH09505292A (ja) 1997-05-27
ES2176263T3 (es) 2002-12-01
NO962018L (no) 1996-07-04
SK64696A3 (en) 1997-03-05
FI962021A0 (fi) 1996-05-13
SK283240B6 (sk) 2003-04-01
NO962018D0 (no) 1996-05-15
MD1560F2 (ro) 2000-11-30
BG100563A (bg) 1996-12-31
AU8090094A (en) 1995-06-06
NZ275318A (en) 1999-06-29
RU2160733C2 (ru) 2000-12-20
SI0729463T1 (en) 2002-08-31
TJ320B (en) 2001-10-22
EP0729463A1 (en) 1996-09-04
FI962021A (fi) 1996-07-12
WO1995014011A2 (en) 1995-05-26
HU9601349D0 (en) 1996-07-29
EP0729463B1 (en) 2002-05-22
CZ136896A3 (en) 1997-12-17
NO315117B1 (no) 2003-07-14
US5936128A (en) 1999-08-10

Similar Documents

Publication Publication Date Title
IL111674A0 (en) 5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them
IL111673A0 (en) 5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them
MY138860A (en) Hiv protease inhibitors.
MD960171A (ro) Derivaţi ai pironei folosiţi ca inhibitori ai proteazei şi agenţi antivirali
IL111672A0 (en) Pyrone derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees